Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients.

Umberto Basile Mariapaola MarinoCecilia NapodanoKrizia PocinoPaolo Emilio AlboiniFrancesca GulliAmelia EvoliCarlo ProvenzanoEmanuela Bartoccioni

Published in: Journal of immunology research (2018)

From our data, FLCs appear to be a sensitive marker of B cell activation in MG. Further investigations are necessary to exploit their potential as reliable biomarkers of disease activity.

Keyphrases

disease activity
rheumatoid arthritis
myasthenia gravis
systemic lupus erythematosus
end stage renal disease
rheumatoid arthritis patients
ejection fraction
newly diagnosed
juvenile idiopathic arthritis
patient reported outcomes
big data